VALNEVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Valneva SE on Behalf of Valneva Stockholders and Encourages Investors to Contact the Firm
1. Bragar Eagel & Squire investigates Valneva for potential securities violations. 2. CDC noted hospitalizations after Valneva's chikungunya vaccine, impacting stock price. 3. FDA suspended IXCHIQ marketing due to safety concerns, causing further stock decline. 4. Investors encouraged to discuss legal rights following significant stock losses. 5. Investigation may highlight unlawful business practices affecting investor confidence.